Phathom Pharmaceuticals Inc (PHAT)

Date: O: H: L: C: Vol:

Finanzdaten der Phathom Pharmaceuticals Inc-Aktie (PHAT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	14.07%84.72	74.27	58.30	57.58	49.50
Cost Of Revenue	21.67%18.37	15.10	12.00	7.65	6.19
Gross Profit	12.13%66.36	59.18	46.31	49.94	43.31
	5.22%66.44	63.14	61.78	55.86	58.59
Selling, General, and Administrative	4.27%57.70	55.33	54.01	48.37	51.56
Research and Development	11.93%8.75	7.81	7.77	7.49	7.03
Operating Income/Loss	97.86%-0.09	-3.97	-15.48	-5.93	-15.27
Nonoperating Income/Loss	1.43%-13.81	-13.62	-14.89	-15.22	-14.70
	20.96%-13.90	-17.58	-30.37	-21.15	-29.97
Attributable To Parent	20.96%-13.90	-17.58	-30.37	-21.15	-29.97
Basic Average Shares	1.37%84.89	83.75	82.05	0.30	73.40
Diluted Average Shares	1.37%84.89	83.75	82.05	0.30	73.40
Basic Earnings Per Share	23.81%-0.16	-0.21	-0.37	-0.27	-0.41
Diluted Earnings Per Share	23.81%-0.16	-0.21	-0.37	-0.27	-0.41